Donald Gallagher Email

Senior Director Process Development . Nitto Denko Avecia

Current Roles

Employees:
745
Revenue:
$115.5M
About
Nitto Denko Avecia is the largest oligonucleotide manufacturer in the world and continues to play an integral role in advancing the oligo therapeutic market. With over 20 years of experience and over 1,000 sequences manufactured, we fulfill our client's needs for pre-clinical, clinical, and launched products. With production capacity in FDA- audited facilities near Boston, MA, and Cincinnati, OH, we produce a novel class of active pharmaceutical ingredients (APIs) -- oligonucleotides -- used by pharmaceutical and biotechnology companies to develop drug treatments for a variety of health indications. In addition to our pre-clinical and CGMP oligo manufacturing capability, we leverage our wealth of expertise to offer a portfolio of services that includes Analytical Development, Process Development, and Quality Control testing.
Nitto Denko Avecia Address
Fortune Blvd.
Milford, MA
United States
Nitto Denko Avecia Email

Past Companies

Nitto AveciaSenior Director of Process Development
Nitto Denko Avecia Inc.Director of Process Development
Nitto AveciaAssociate Director of Process Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.